This group, which includes the Society of Obstetricians & Gynaecologists of Canada and the SIGMA Canadian Menopause Society, spoke in favor of hormone therapy.
“Too many postmenopausal women are deprived of the benefits of hormone therapy,” reads the statement issued by the group of researchers, and has been a study by the Women’s Health Initiative indicated that the hormones outweighed the dangers their benefits.
“The results of this study, which examined the long-term effects of hormone therapy, were misinterpreted by postmenopausal women,” said Dr. Margery Gass, the North American Menopause Society. “That’s why we decided to meet important medical associations to arrive at a consensus about the use of hormone therapy,” she adds.
This treatment involves taking hormone replacement after menopause (estrogen and progesterone) to relieve and treat symptoms such as vaginal dryness, hot flashes, mood swings and osteoporosis.
Among the risks and side effects of hormone therapy, there are blood clots, stroke and breast cancer.
The group of 15 medical associations have concluded that hormone therapy is appropriate for healthy postmenopausal women, and until the age of 59. Moreover, the risk of breast cancer increases as from five years of follow-up treatment for estrogen and progesterone. The risks are reduced when treatment is discontinued.